Lisdexamfetamine Dimesylate 42291-0041-90
Generic: Lisdexamfetamine
- Manufacturer
- Avkare
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- June 4, 2025
- Listing Expires
- December 31, 2026
- Application
- ANDA202830
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lisdexamfetamine Dimesylate | 70 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulation [PE]
Selected Package
42291-0041-90Selected90 CAPSULE in 1 BOTTLE (42291-041-90)